Showing 1 - 7 results of 7 for search 'Erik A Ranheim', query time: 0.04s Refine Results
  1. 1
    Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case

    Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case by Daniel J. Robbins, Erik A. Ranheim, Jamie E. Kallan

    Published 2023-03-01
    Get full text
    Article
  2. 2
    GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis

    GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis by Xin Gao, Tongyu Wu, Kirby D. Johnson, Jamie L. Lahvic, Erik A. Ranheim, Leonard I. Zon, Emery H. Bresnick

    Published 2016-03-01
    Get full text
    Article
  3. 3
    Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition

    Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition by Kran Suknuntha, Kran Suknuntha, Kran Suknuntha, Yoon Jung Choi, Ho Sun Jung, Aditi Majumder, Sujal Shah, Igor Slukvin, Igor Slukvin, Erik A. Ranheim

    Published 2020-12-01
    Get full text
    Article
  4. 4
    An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.

    An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. by James C Romero-Masters, Makoto Ohashi, Reza Djavadian, Mark R Eichelberg, Mitch Hayes, Jillian A Bristol, Shidong Ma, Erik A Ranheim, Jenny Gumperz, Eric C Johannsen, Shannon C Kenney

    Published 2018-08-01
    Get full text
    Article
  5. 5
    EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.

    EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mi... by Chunrong Li, James C Romero-Masters, Shane Huebner, Makoto Ohashi, Mitchell Hayes, Jillian A Bristol, Scott E Nelson, Mark R Eichelberg, Nicholas Van Sciver, Erik A Ranheim, Rona S Scott, Eric C Johannsen, Shannon C Kenney

    Published 2020-06-01
    Get full text
    Article
  6. 6
    B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.

    B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. by James C Romero-Masters, Shane M Huebner, Makoto Ohashi, Jillian A Bristol, Bayleigh E Benner, Elizabeth A Barlow, Gail L Turk, Scott E Nelson, Dana C Baiu, Nicholas Van Sciver, Erik A Ranheim, Jenny Gumperz, Nathan M Sherer, Paul J Farrell, Eric C Johannsen, Shannon C Kenney

    Published 2020-02-01
    Get full text
    Article
  7. 7
    Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

    Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab by Amy K. Erbe, Wei Wang, Lakeesha Carmichael, Anna Hoefges, Bartosz Grzywacz, Patrick K. Reville, Erik A. Ranheim, Jacquelyn A. Hank, KyungMann Kim, Songwon Seo, Eneida A. Mendonca, Yiqiang Song, Vaishalee P. Kenkre, Fangxin Hong, Randy D. Gascoyne, Elisabeth Paietta, Sandra J. Horning, Jeffrey S. Miller, Brad Kahl, Paul M. Sondel

    Published 2019-03-01
    Get full text
    Article

Search Tools: